Catherine Godfrey

4.5k total citations
80 papers, 2.8k citations indexed

About

Catherine Godfrey is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Catherine Godfrey has authored 80 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 38 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Catherine Godfrey's work include HIV/AIDS Research and Interventions (42 papers), HIV Research and Treatment (38 papers) and HIV/AIDS drug development and treatment (30 papers). Catherine Godfrey is often cited by papers focused on HIV/AIDS Research and Interventions (42 papers), HIV Research and Treatment (38 papers) and HIV/AIDS drug development and treatment (30 papers). Catherine Godfrey collaborates with scholars based in United States, South Africa and Brazil. Catherine Godfrey's co-authors include Roy M. Gulick, Ann C. Collier, Timothy Wilkin, Grace A. McComsey, Daniel R. Kuritzkes, Robert Gross, Michael D. Hughes, John W. Mellors, Paul R. Skolnik and Wayne Greaves and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Catherine Godfrey

78 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Godfrey United States	25	1.8k	1.3k	752	651	357	80	2.8k
Katherine Huppler Hullsiek United States	31	1.6k 0.9×	1.2k 0.9×	1.1k 1.5×	672 1.0×	272 0.8×	52	2.9k
William Towner United States	27	2.3k 1.3×	1.3k 1.0×	1.2k 1.6×	1.1k 1.7×	266 0.7×	80	3.6k
Maria Jesús Pérez‐Elías Spain	29	2.4k 1.3×	1.7k 1.3×	1.1k 1.4×	786 1.2×	164 0.5×	179	3.4k
Guillem Sirera Spain	24	1.1k 0.6×	778 0.6×	767 1.0×	391 0.6×	315 0.9×	59	2.0k
Princy Kumar United States	30	2.7k 1.5×	1.7k 1.3×	1.4k 1.8×	751 1.2×	175 0.5×	127	3.8k
Michael P. Dubé United States	33	1.9k 1.1×	1.2k 0.9×	926 1.2×	1.5k 2.3×	277 0.8×	96	3.2k
Eduardo Sprinz Brazil	26	1.5k 0.9×	968 0.7×	503 0.7×	722 1.1×	116 0.3×	92	2.2k
Jason V. Baker United States	33	1.9k 1.1×	1.7k 1.3×	856 1.1×	2.2k 3.4×	298 0.8×	103	3.7k
Kathy Petoumenos Australia	30	1.6k 0.9×	930 0.7×	1.9k 2.6×	1.0k 1.6×	708 2.0×	133	3.7k
Philippe Morlat France	33	2.1k 1.2×	1.0k 0.8×	1.8k 2.3×	1.5k 2.4×	237 0.7×	109	4.2k

Countries citing papers authored by Catherine Godfrey

Since Specialization

Citations

This map shows the geographic impact of Catherine Godfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Godfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Godfrey more than expected).

Fields of papers citing papers by Catherine Godfrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Godfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Godfrey. The network helps show where Catherine Godfrey may publish in the future.

Co-authorship network of co-authors of Catherine Godfrey

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Godfrey. A scholar is included among the top collaborators of Catherine Godfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Godfrey. Catherine Godfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lessa, Fernanda C., et al.. (2025). The Case for Strengthening Infection Prevention and Control in Primary Care. The Journal of Infectious Diseases. 232(Supplement_2). S140–S144.

Henrich, Timothy J., Ronald J. Bosch, Catherine Godfrey, et al.. (2024). Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV. Cell Reports Medicine. 5(10). 101745–101745. 5 indexed citations

Tobin, Nicole H., Sarah L Brooker, Fan Li, et al.. (2024). Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. The Journal of Infectious Diseases. 231(3). 583–594. 2 indexed citations

Scarsi, Kimberly K., Laura Smeaton, Anthony T. Podany, et al.. (2023). Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens. Contraception. 121. 109951–109951. 6 indexed citations

Epeldegui, Marta, Di Chang, Jeannette Y. Lee, et al.. (2023). Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 94(2). 165–173. 4 indexed citations

Chang, David, Allahna Esber, Nicole Dear, et al.. (2022). Non‐communicable diseases by age strata in people living with and without HIV in four African countries. Journal of the International AIDS Society. 25(S4). e25985–e25985. 7 indexed citations

Roy, Jason, Michael Z. Levy, Carole L. Wallis, et al.. (2021). Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis. AIDS Patient Care and STDs. 35(12). 467–473. 2 indexed citations

Silva, Juliana da, et al.. (2021). Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir. The Journal of Infectious Diseases. 225(3). 364–366. 10 indexed citations

Godfrey, Catherine, Thomas Minior, B. Ryan Phelps, et al.. (2020). PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa. Journal of the International AIDS Society. 23(8). e25587–e25587. 44 indexed citations

10.

Haas, David W., Yoninah Cramer, Catherine Godfrey, et al.. (2020). Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives. Pharmacogenetics and Genomics. 30(3). 45–53. 8 indexed citations

11.

Ake, Julie A., et al.. (2020). Sex Differences in the Treatment of HIV. Current HIV/AIDS Reports. 17(4). 373–384. 10 indexed citations

12.

Mngqibisa, Rosie, Michelle A. Kendall, Kelly E. Dooley, et al.. (2019). Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency. Clinical Infectious Diseases. 71(3). 517–524. 7 indexed citations

13.

Gandhi, Rajesh T., Deborah K. McMahon, Ronald J. Bosch, et al.. (2017). Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathogens. 13(4). e1006285–e1006285. 130 indexed citations

14.

Rossouw, Theresa M., et al.. (2017). Barriers to HIV remission research in low‐ and middle‐income countries. Journal of the International AIDS Society. 20(1). 21521–21521. 17 indexed citations

15.

Godfrey, Catherine, Janet Andersen, Rosie Mngqibisa, Lesley Scott, & Francesca Conradie. (2016). inform investments for health R & D. The Lancet. 1 indexed citations

16.

Lennox, JL, et al.. (2014). Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1 (vol 161, pg 461, 2014). eScholarship (California Digital Library). 4 indexed citations

17.

Vogler, Mary, Laura Smeaton, Rodney Wright, et al.. (2013). Combination Antiretroviral Treatment for Women Previously Treated Only in Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(5). 542–550. 4 indexed citations

18.

Gulick, Roy M., Zhaohui Su, Charles Flexner, et al.. (2007). Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV‐1–Infected, Treatment‐Experienced Patients: AIDS Clinical Trials Group 5211. The Journal of Infectious Diseases. 196(2). 304–312. 195 indexed citations

19.

Wilkin, Timothy, Zhaohui Su, Daniel R. Kuritzkes, et al.. (2007). HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211. Clinical Infectious Diseases. 44(4). 591–595. 131 indexed citations

20.

Lewis, Sarah, Deborah Arnott, Catherine Godfrey, & John Britton. (2005). Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?. Tobacco Control. 14(4). 251–254. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact